Cell proliferation assay demonstrated significant differences between CAFs with or without tumour supernatant/knockdown of NCL/MDK inhibitor, underlining the importance of MDK–NCL pathway in early ESCC microenvironment. This evidence concerns the gene MDK and esophageal squamous cell carcinoma.